Theanine

Theanine
L-Theanine
Clinical data
Other namesγ-L-Glutamylethylamide
Dependence
liability
None
Routes of
administration
Oral
ATC code
  • none
Legal status
Legal status
  • US: OTC
  • UN: Unscheduled
Pharmacokinetic data
Onset of action~1 hour
Elimination half-lifeCapsule: ~1.2 hours
Green Tea: ~0.8 hours
Identifiers
  • (2S)-2-Ammonio-5-(ethylamino)-5-oxopentanoate or N-Ethyl-L-glutamine
CAS Number
PubChem CID
DrugBank
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard100.019.436
Chemical and physical data
FormulaC7H14N2O3
Molar mass174.200 g·mol−1
3D model (JSmol)
Melting point174.20 °C (345.56 °F)
Boiling point215 °C (419 °F)
  • CCNC(=O)CC[C@H](N)C(=O)O

  • CCNC(=O)CCC(N)C(O)=O
  • InChI=1S/C7H14N2O3/c1-2-9-6(10)4-3-5(8)7(11)12/h5H,2-4,8H2,1H3,(H,9,10)(H,11,12) Y
  • Key:DATAGRPVKZEWHA-UHFFFAOYSA-N Y

Theanine /ˈθənn/, also known as L-γ-glutamylethylamide, N5-ethyl-L-glutamine, or γ-glutamylethylamide, is a bioactive, non-proteinogenic amino acid similar to the proteinogenic amino acids glutamic acid and L-glutamine. It is produced by certain plants such as the tea plant (Camellia sinensis), and by some fungi. Theanine was discovered in 1949 as a constituent of green tea and was isolated in 1950 from gyokuro tea leaves. Theanine constitutes about 1–2% of the dry weight of green tea leaves.

Theanine is sold as a dietary supplement. It is packaged in gelatin capsules, tablets, and as a powder, and may be an ingredient in branded supplements with caffeine. It is also used as an ingredient in food and beverages. Japan approved its unlimited use in all foods (including chocolates, soft drinks, and herb teas) except infant food in 1964, and the US Food and Drug Administration has considered it to be safe at doses up to 250 milligrams (mg) per serving since 2007.

In 2011, the European Food Safety Authority found there was insufficient evidence for a causal relationship between theanine consumption and improved cognitive function, alleviation of psychological stress, maintenance of normal sleep, or reduction of menstrual discomfort. A 2025 review found that theanine has been poorly studied to date, having inconsistent research quality and unreliable clinical trials.